Novo Nordisk (NVO) and more specifically its weight-loss drugs Ozempic and Wagovy have been the topic of many conversations across Wall Street. The company’s financial performance, impact and buzz has lead to Yahoo Finance naming Novo Nordisk its 2023 Company of the Year. Novo Nordisk CEO Lars Fruergaard Jorgensen spoke with Yahoo Finance Senior Health Reporter Anjalee Khemlani and Yahoo Finance reporters take a closer look at the success and impacts on December 11, 2023.
About Yahoo Finance:
Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage your financial life.
– Get the latest news and data at finance.yahoo.com
– Download the Yahoo Finance app on Apple (https://apple.co/3Rten0R) or Android (https://bit.ly/3t8UnXO)
– Follow Yahoo Finance on social:
X: http://twitter.com/YahooFinance
Instagram: https://www.instagram.com/yahoofinance/?hl=en
TikTok: https://www.tiktok.com/@yahoofinance?lang=en
Facebook: https://www.facebook.com/yahoofinance/
LinkedIn: https://www.linkedin.com/company/yahoo-finance
#novonordisk #ozempic #wegovy #yahoofinance
Yes
I have this stockNVO and LLY but they fluctuate a lot. I would like to understand why?
Constant buying/selling day in and day out tend to cause rapid fluctuations in price.
Bitcoin go up soon
Pourquoi?
Lol finance people aren’t good humans
Pourquoi pas?
to tackle obesity problem, i propose that government should ban high levels of sugar in food, specially supermarket processed food
Great company and a high quality long-term stock. Interestingly , the only Pharma company I know, without goodwill in the balance sheet. But the stock is very expensive and the fair value of the stock is currently uncertain.